An Evaluation of Levalbuterol HFA in the Prevention of Exercise-Induced Bronchospasm

References

• Parsons J P, Mastronarde J G. Exercise-induced bronchoconstriction in athletes. Chest 2005; 128: 3966–3974
   PubMed Web of Science ®Google Scholar
• Anderson S D, Caillaud C, Brannan J D. Beta2-agonists and exercise-induced asthma. Clin Rev Allergy Immunol 2006; 31: 163–180
   PubMed Web of Science ®Google Scholar
• Clark C J, Cochrane L M. Physical activity and asthma. Curr Opin Pulm Med 1999; 5: 68–75
   PubMedGoogle Scholar
• Meyer R, Kroner-Herwig B, Sporkel H. The effect of exercise and induced expectations on visceral perception in asthmatic patients. J Psychosom Res 1990; 34: 455–460
   PubMedGoogle Scholar
• Ergood J S, Epstein L H, Ackerman M, Fireman P. Perception of expiratory flow by asthmatics and non-asthmatics during rest and exercise. Health Psychol 1985; 4: 545–554
   PubMedGoogle Scholar
• Panditi S, Silverman M. Perception of exercise induced asthma by children and their parents. Arch Dis Child 2003; 88: 807–811
   PubMed Web of Science ®Google Scholar
• NHLBI. Guidelines for the diagnosis and management of asthma. National Institutes of Health. 1997, Report: 97-4051
   Google Scholar
• Penn R B, Frielle T, McCullough J R, Aberg G, Benovic J L. Comparison of R-, S-, and RS-albuterol interaction with human beta 1- and beta 2-adrenergic receptors. Clin Rev Allergy Immunol 1996; 14: 37–45
   PubMed Web of Science ®Google Scholar
• Lotvall J, Palmqvist M, Arvidsson P, Maloney A, Ventresca G P, Ward J. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients. J Allergy Clin Immunol 2001; 108: 726–731
   PubMed Web of Science ®Google Scholar
• Milgrom H. Levosalbutamol in the treatment of asthma. Expert Opin Pharmacother 2006; 7: 1659–1668
   PubMed Web of Science ®Google Scholar
• Berkowitz R, Schwartz E, Bukstein D, Grunstein M, Chai H. Albuterol protects against exercise-induced asthma longer than metaproterenol sulfate. Pediatrics 1986; 77: 173–178
   PubMedGoogle Scholar
• Hawksworth R J, Sykes A P, Faris M, Mant T, Lee T H. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction. Ann Allergy Asthma Immunol 2002; 88: 473–477
   PubMed Web of Science ®Google Scholar
• Shapiro G S, Yegen U, Xiang J, Kottakis J, Della C G. A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol. Clin Ther 2002; 24: 2077–2087
   PubMed Web of Science ®Google Scholar
• Sichletidis L, Daskalopoulou E, Kyriazis G, Kosmidou I, Koupidou S, Pechlivanidis T, Chloros D. Comparative efficacy of salbutamol and salmeterol in exercise-induced asthma. J Int Med Res 1993; 21: 81–88
   PubMed Web of Science ®Google Scholar
• Inman M, O'Byrne P. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med 1996; 153: 65–69
   PubMed Web of Science ®Google Scholar
• Crapo R O, Casaburi R, Coates A L, Enright P L, Hankinson J L, Irvin C G, MacIntyre N R, McKay R T, Wanger J S, Anderson S D, Cockcroft D W, Fish J E, Sterk P J. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, 1999. Am J Respir Crit Care Med 2000; 161: 309–329
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services FC. Guidance for Industry;Exercise-induced bronchospasm (EIB)—development of drugs to prevent EIB (draft). 2002
   Google Scholar
• McFadden E R, Jr., Gilbert I A. Exercise-induced asthma. N Engl J Med 1994; 12(330)1362–1367
   Google Scholar
• Jones B, Kenward M. Design and analysis of cross-over trials (monographs on statistics and applied probability), 2nd ed. Chapman & Hall, Boca Raton, FL 2003
   Google Scholar
• Littell R C, Milliken G A, Stroup W W, Wolfinger R D. SAS systems for mixed models. SAS Publishing, Cary, NC 1996
   Google Scholar
• Sterk P J, Fabbri L M, Quanjer P H, Cockcroft D W, O'Byrne P M, Anderson S D, Juniper E F, Malo J L. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 53–83
   PubMedGoogle Scholar
• Anderson S D, Lambert S, Brannan J D, Wood R J, Koskela H, Morton A R, Fitch K D. Laboratory protocol for exercise asthma to evaluate salbutamol given by two devices. Med Sci Sports Exerc 2001; 33: 893–900
   PubMed Web of Science ®Google Scholar
• Task force on recognizing and diagnosing exercise-related asthma, respiratory and allergic disorder in sports. Evidence-based recommendations for the diagnosis of exercise-induced asthma in athletes. Eur Respir Mon 2005; 33: 102–104
   Google Scholar
• Senn S J. The use of baselines in clinical trials of bronchodilators. Stat Med 1989; 8: 1339–1350
   PubMed Web of Science ®Google Scholar
• Boner A L, Spezia E, Piovesan P, Chiocca E, Maiocchi G. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children. Am J Respir Crit Care Med 1994; 149(4 Pt 1)935–939
   PubMedGoogle Scholar
• Johnson M. Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol 2006; 117: 18–24
   PubMed Web of Science ®Google Scholar
• Hancox R J, Subbarao P, Kamada D, Watson R M, Hargreave F E, Inman M D. Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med 2002; 165: 1068–1070
   PubMed Web of Science ®Google Scholar
• Haney S, Hancox R J. Rapid onset of tolerance to beta-agonist bronchodilation. Respir Med 2005; 99: 566–571
   PubMed Web of Science ®Google Scholar
• Hayes M J, Qing F, Rhodes C G, Rahman S U, Ind P W, Sriskandan S, Jones T, Hughes J M. In vivo quantification of human pulmonary beta-adrenoceptors: effect of beta-agonist therapy. Am J Respir Crit Care Med 1996; 154: 1277–1283
   PubMed Web of Science ®Google Scholar
• Anderson S D. Single-dose agents in the prevention of exercise-induced asthma: a descriptive review. Treat Respir Med 2004; 3: 365–379
   PubMedGoogle Scholar
• Vathenen A S, Knox A J, Wisniewski A, Tattersfield A E. Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma. Thorax 1991; 46: 811–816
   PubMed Web of Science ®Google Scholar
• Vidal C, Fernandez-Ovide E, Pineiro J, Nunez R, Gonzalez-Quintela A. Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction. Ann Allergy Asthma Immunol 2001; 86: 655–658
   PubMed Web of Science ®Google Scholar
• Pedersen S, Hansen O R. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol 1995; 95(1 Pt 1)29–33
   PubMed Web of Science ®Google Scholar